APLS vs DVN · rev $1.00B vs P/E 7.4, rev $7.42B
Apellis Pharmaceuticals Inc (APLS) versus Devon Energy Corporation (DVN) — a side-by-side from cached financials, not a winner call.
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
Devon Energy Corporation (DVN) is a oil & gas e&p company listed on US.
Latest reported APLS revenue for 2025-12-31 was $1.00B. Net income was $22.4M. Revenue was up 28.5% from 2024-12-31 to 2025-12-31. APLS currently screens at market cap $2.29B.
Latest reported DVN revenue for 2026-06-30 was $7.42B. Net income was $1.91B. Revenue was up 94.8% from 2026-03-31 to 2026-06-30. DVN currently screens at market cap $22.42B and trailing P/E 7.4.
APLS currently screens at market cap $2.29B. DVN currently screens at market cap $22.42B and trailing P/E 7.4.
Not investment advice. Open the APLS and DVN stock pages for the full models.
Not investment advice.